Insulet
PODD
#2071
Rank
S$12.82 B
Marketcap
S$184.97
Share price
1.20%
Change (1 day)
-57.60%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Earnings for Insulet (PODD)

Earnings in 2026 (TTM): S$0.60 Billion

According to Insulet's latest financial reports the company's current earnings are S$2.90 Billion. In 2025 the company made an earning of S$0.50 Billion, an increase over its 2024 earnings that were of S$0.43 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Insulet from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) S$0.60 B18.55%
2025 S$0.50 B16.3%
2024 S$0.43 B36.76%
2023 S$0.31 B481.9%
2022 S$54.93 M-45.24%
2021 S$0.10 B43.35%
2020 S$69.97 M18.51%
2019 S$59.04 M41.16%
2018 S$41.82 M-711.95%
2017 -S$6.84 Million-56.85%
2016 -S$15.85 Million-79.31%
2015 -S$76.58 Million63.85%
2014 -S$46.74 Million31.04%
2013 -S$35.67 Million-21.96%
2012 -S$45.71 Million
2010 -S$43.6 Million-42.38%
2009 -S$75.66 Million-33.56%
2008 -S$0.12 Billion65.93%
2007 -S$68.63 Million209.75%
2006 -S$22.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
S$33.11 B 5,436.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$10.37 B 1,634.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
S$8.73 B 1,360.14%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
S$39.66 B 6,533.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
-S$0.13 Billion-120.90%๐Ÿ‡บ๐Ÿ‡ธ USA
ICU Medical
ICUI
S$0.12 B-79.14%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
S$1.55 B 160.08%๐Ÿ‡บ๐Ÿ‡ธ USA